Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin H Mullish

Showing results (61-70 of 146) with videos related to

Pageof 15
Sort By:
BMC Gastroenterology|April 4, 2014
Severe cholestatic jaundice after a single administration of ajmaline; a case report and review of the literatureBenjamin H Mullish, Rishi K Fofaria, Belinda C Smith, et al.
The Analyst|October 8, 2024
Evaluating protocols for reproducible targeted metabolomics by NMRDarcy Cochran, Panteleimon G Takis, James L Alexander, et al.
Methods (San Diego, Calif.)|April 29, 2018
Functional microbiomics: Evaluation of gut microbiota-bile acid metabolism interactions in health and diseaseBenjamin H Mullish, Alexandros Pechlivanis, Grace F Barker, et al.
Gut|July 7, 2021
Rapid resolution of COVID-19 after faecal microbiota transplantationJarosław Biliński, Katarzyna Winter, Marcin Jasiński, et al.
Human Vaccines & Immunotherapeutics|November 13, 2023
Gut microbiota and immunotherapy of renal cell carcinomaStefano Bibbò, Serena Porcari, Livio Enrico Del Vecchio, et al.
Gut Microbes|September 6, 2018
Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathwayTanya Monaghan, Benjamin H Mullish, Jordan Patterson, et al.
Future Microbiology|September 21, 2020
Fecal microbiota transplantation in gastrointestinal and extraintestinal disordersGianluca Ianiro, Jonathan P Segal, Benjamin H Mullish, et al.
Journal for Immunotherapy of Cancer|November 8, 2019
Antibiotic therapy and outcome from immune-checkpoint inhibitorsDavid J Pinato, Daria Gramenitskaya, Daniel M Altmann, et al.
Therapeutic Advances in Gastroenterology|December 7, 2020
The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?Jonathan P Segal, Joyce W Y Mak, Benjamin H Mullish, et al.
Frontline Gastroenterology|December 31, 2021
Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infectionsRooshi Nathwani, David Kockerling, Benjamin H Mullish, et al.
Pageof 15

Showing results (61-70 of 146) with videos related to

Sort By:
Pageof 15
BMC Gastroenterology|April 4, 2014
Severe cholestatic jaundice after a single administration of ajmaline; a case report and review of the literatureBenjamin H Mullish, Rishi K Fofaria, Belinda C Smith, et al.
The Analyst|October 8, 2024
Evaluating protocols for reproducible targeted metabolomics by NMRDarcy Cochran, Panteleimon G Takis, James L Alexander, et al.
Methods (San Diego, Calif.)|April 29, 2018
Functional microbiomics: Evaluation of gut microbiota-bile acid metabolism interactions in health and diseaseBenjamin H Mullish, Alexandros Pechlivanis, Grace F Barker, et al.
Gut|July 7, 2021
Rapid resolution of COVID-19 after faecal microbiota transplantationJarosław Biliński, Katarzyna Winter, Marcin Jasiński, et al.
Human Vaccines & Immunotherapeutics|November 13, 2023
Gut microbiota and immunotherapy of renal cell carcinomaStefano Bibbò, Serena Porcari, Livio Enrico Del Vecchio, et al.
Gut Microbes|September 6, 2018
Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathwayTanya Monaghan, Benjamin H Mullish, Jordan Patterson, et al.
Future Microbiology|September 21, 2020
Fecal microbiota transplantation in gastrointestinal and extraintestinal disordersGianluca Ianiro, Jonathan P Segal, Benjamin H Mullish, et al.
Journal for Immunotherapy of Cancer|November 8, 2019
Antibiotic therapy and outcome from immune-checkpoint inhibitorsDavid J Pinato, Daria Gramenitskaya, Daniel M Altmann, et al.
Therapeutic Advances in Gastroenterology|December 7, 2020
The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?Jonathan P Segal, Joyce W Y Mak, Benjamin H Mullish, et al.
Frontline Gastroenterology|December 31, 2021
Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infectionsRooshi Nathwani, David Kockerling, Benjamin H Mullish, et al.
Pageof 15